J. Casado

C. Quereda, Ó. Pastor, S. Moreno, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

THU0483 Bone mineral density and prevalence of osteoporosis in hiv-infected patients in comparison with a reference spanish population: the importance of local normative ranges

J. Casado, M. Vivancos, M. P. Pérez Elías, 2018, THURSDAY, 14 JUNE 2018.

Focal Monophasic Demyelinating Leukoencephalopathy in Advanced HIV Infection

M. García-Villanueva, A. Ariza, C. Quereda, 2004, European Neurology.

[Meningoencephalitis: an unusual complication of influenza vaccine].

J. Casado, A. Blanco, J. L. López Domínguez, 1999, Medicina clinica.

Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients.

S. Moreno, J. Casado, A. Moreno, 2015, Antiviral Research.

Liver toxicity in HIV-infected patients receiving novel second-generation nonnucleoside reverse transcriptase inhibitors etravirine and rilpivirine.

J. Casado, 2013, AIDS reviews.

Unravelling hip–spine bone mineral density discordance in people living with HIV

J. Casado, P. Vizcarra, M. Vivancos, 2022, Journal of Bone and Mineral Metabolism.

Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection

J. Casado, S. Bañón, 2015, Expert review of clinical pharmacology.

[Cerebrovascular complications in patients with cancer].

A. Gil-Peralta, J. Casado, C. Jl, 1995, Revista de neurologia.

Vascular disease in HIV-infected patients: a comparative study of two different therapeutic periods (1994-1997 versus 1998-2000).

S. Moreno, M. Pérez-Elías, A. Antela, 2002, AIDS.

SARS-CoV-2 cellular immune response in uninfected health care workers with prolonged and close exposure to COVID-19 patients

C. Quereda, J. Casado, P. Vizcarra, 2020 .

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response

M. Esteban, C. Quereda, S. Moreno, 2015, Digestive Diseases and Sciences.

Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART).

R. López-Vélez, J. Casado, V. Pintado, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Weight gain in people living with HIV switched to dual therapy: changes in body fat mass.

M. Pérez-Elías, J. Casado, P. Vizcarra, 2019, AIDS.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting

S. Moreno, J. Casado, P. Vizcarra, 2019, HIV research & clinical practice.

High Rate of Didanosine-Related Mitochondrial Toxicity in HIV/HCV-Coinfected Patients Receiving Ribavirin

A. Muriel, C. Quereda, E. Navas, 2004, Antiviral therapy.

Proximal tubular renal dysfunction or damage in HIV-infected patients.

J. Casado, M. D. del Palacio, Sara Romero, 2012, AIDS reviews.

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score

C. Quereda, B. Hernández-Novoa, S. Moreno, 2011, AIDS.

Improving Recognition of Fracture Risk in People with Human Immunodeficiency Virus: Performance and Model Contribution of Two Common Risk Assessment Tools.

J. Casado, P. Vizcarra, M. Vivancos, 2022, AIDS Patients Care and STDs.

Sexualized Drug Use (Chemsex) Is Associated with High‐Risk Sexual Behaviors and Sexually Transmitted Infections in HIV‐Positive Men Who Have Sex with Men: Data from the U‐SEX GESIDA 9416 Study

J. Troya, P. Ryan, J. Casado, 2018, AIDS patient care and STDs.

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

C. Quereda, S. Moreno, M. Pérez-Elías, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anti‐Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity

F. Graus, A. Gil-Peralta, J. Casado, 1994, Neurology.

Acute mediastinitis due toRhodococcus equi in a patient with human immunodeficiency virus infection

M. Meseguer, A. Antela, J. Casado, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome

M. Pérez-Elías, J. Casado, A. Moreno, 1996, Clinical endocrinology.

Salmonella lung involvement in patients with HIV infection.

A. Guerrero, E. Navas, J. Casado, 1997, Chest.

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy

C. Tural, R. Schuurman, J. Casado, 1999 .

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.

C. Tural, R. Schuurman, J. Casado, 1999, AIDS.

Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients.

J. Martínez-Beltrán, A. Guerrero, E. Navas, 1999, The Journal of infectious diseases.

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use

J. Zamora, A. Muriel, C. Quereda, 2004, AIDS.

Renal and Bone Toxicity with the Use of Tenofovir: Understanding at the End.

J. Casado, 2016, AIDS reviews.

Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study.

E. Martinez, J. Navarro, A. Curran, 2020, The Journal of antimicrobial chemotherapy.

Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?

J. Mallolas, V. Soriano, L. López-Cortés, 2005, Enfermedades infecciosas y microbiologia clinica.

Cytomegalovirus polyradiculopathy treated successfully with foscarnet

A. Guerrero, C. Quereda, J. Casado, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Effectiveness and Pitfalls of Initial Highly Active Antiretroviral Therapy in HIV-Infected Patients in Routine Clinical Practice

C. Quereda, E. Navas, M. Pérez-Elías, 1999, Antiviral therapy.

Prevention of opportunistic infections in HIV-infected adolescent and adult patients . Guidelines from GESIDA / National AIDS Plan , 2008

D. Podzamczer, Miguel, Moreno, 2009 .

CD4 count and viral load time‐courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system

J. Casado, H. Knobel, J. Collazos, 2006, HIV medicine.

Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.

K. Hertogs, S. Moreno, A. Antela, 2001, AIDS research and human retroviruses.

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression.

S. Moreno, M. Pérez-Elías, A. Antela, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment

J. Casado, P. Vizcarra, M. Vivancos, 2019, International journal of STD & AIDS.

Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age

S. Moreno, J. Casado, W. A. Sifuentes, 2018, Archives of Osteoporosis.

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study

J. Casado, A. Ocampo, J. M. Kindelán, 2002, AIDS.

Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life

J. Casado, P. Vizcarra, A. Vallejo, 2022, Journal of clinical medicine.

Solitary pulmonary nodule due to Leishmania in a patient with AIDS.

A. Guerrero, J. Casado, C. Cuesta, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of the Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated With Cyclin-Dependent Kinases 4 and 6 Inhibitors (CDKi): Limited T-Cell Immunity Despite Satisfactory Humoral Response.

A. Carrato, F. Longo, J. Casado, 2021 .

Semiquantitative culture of subcutaneous segment for conservative diagnosis of intravascular catheter-related infection.

Á. Asensio, A. Guerrero, J. Pérez-Molina, 2000, JPEN. Journal of parenteral and enteral nutrition.

Predictors of long‐term response to protease inhibitor therapy in a cohort of HIV‐infected patients

C. Quereda, M. Pérez-Elías, A. Antela, 1998, AIDS.

Acute polyradiculopathies in HIV-infected patients

A. Guerrero, C. Quereda, E. Navas, 1997, Journal of Neurology.

Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis

P. Martín-Dávila, C. Quereda, E. Navas, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Hot Immunological Topics in HIV Infection

J. Blanco, J. Alcamí, J. Pineda, 2011 .

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments

A. Carrato, F. Longo, J. Casado, 2022, European Journal of Cancer.

Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

J. Casado, P. Vizcarra, A. Vallejo, 2022, Frontiers in Microbiology.

BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity

J. Casado, P. Vizcarra, A. Vallejo, 2021, Vaccine.

T‐cell response after first dose of BNT162b2 SARS‐CoV‐2 vaccine among healthcare workers with previous infection or cross‐reactive immunity

J. Casado, P. Vizcarra, A. Vallejo, 2021, Clinical & translational immunology.

Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.

C. Quereda, S. Moreno, M. Pérez-Elías, 2008, AIDS.

[GESIDA/SEFH/PNS recommendations to improve adherence to antiretroviral therapy in 2004].

I. Escobar, F. Segura, J. Casado, 2004, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.

A. Antela, J. Casado, P. Montilla, 1997, AIDS.

Missing Scheduled Visits in the Outpatient Clinic as a Marker of Short-Term Admissions and Death

A. Muriel, S. Moreno, M. Pérez-Elías, 2012, HIV clinical trials.

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

M. Leal, Y. Pacheco, C. Quereda, 2020, Journal of clinical medicine.

M. Torrens, Jorge Valencia, J. Troya, 2019, bioRxiv.

HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1

C. Quereda, M. Pérez-Elías, J. Casado, 2022, Viruses.

Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors

J. Masjuán, A. Muriel, C. Quereda, 2009, Cerebrovascular Diseases.

Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug Use and the Impact on Clinical Outcomes

N. Garin, Á. Jaén, J. Casado, 2021, AIDS and Behavior.

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1–HCV-Coinfected Patients Who Either Received Interferon-&agr;/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance

C. Quereda, S. Moreno, M. Pérez-Elías, 2015, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Factors associated with the number of drugs in darunavir/cobicistat regimens.

E. Negredo, E. Ribera, M. Pérez-Elías, 2019, The Journal of antimicrobial chemotherapy.

Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV‐1‐infected patients: the TRILOBITHE pilot study

J. Casado, A. Vallejo, M. Molano, 2019, HIV medicine.

High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

R. Toledano, J. Masjuán, A. Muriel, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.

M. Pérez-Elías, J. Casado, A. Moreno, 2014, European journal of endocrinology.

Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers

J. Casado, P. Vizcarra, A. Vallejo, 2022, Frontiers in Microbiology.

The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.

S. Moreno, J. Casado, A. Moreno, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The signi fi cance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunode fi ciency virus-infected patients

S. Moreno, J. Casado, A. Moreno, 2013 .

Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.

A. Royuela, C. Quereda, E. Navas, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens

R. Lanier, S. Moreno, M. Pérez-Elías, 2000, AIDS.

Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen

K. Hertogs, S. Moreno, M. Pérez-Elías, 2002, AIDS.

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

D. Cattaneo, C. Spinner, C. Hoffmann, 2020, HIV medicine.

Impact of a structured HIV testing program in a hospital emergency department and a primary care center

A. Muriel, C. Quereda, E. Navas, 2019, PloS one.

Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected

J. Zamora, M. Muñoz-Fernández, E. Muñoz, 2011, PloS one.

Observational Study to Evaluate Clinical Outcomes After First-Line Efavirenz-or Lopinavir-Ritonavir-Based HAART in Treatment-Naive Patients

C. Quereda, E. Navas, S. Moreno, 2009, Journal of the International Association of Physicians in AIDS Care.

High cytomegalovirus antigenemia levels and cytomegalovirus syndrome in patients with AIDS.

A. Guerrero, J. Casado, Á. Cañizares, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening

A. Muriel, C. Quereda, S. Moreno, 2016, Medicine.

Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy.

P. Martín-Dávila, E. Navas, E. Gómez-Mampaso, 2002, Archives of internal medicine.

Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

Á. Holguín, B. Hernández-Novoa, S. Moreno, 2013, HIV clinical trials.

Phenotype or Virtual Phenotype for Choosing Antiretroviral Therapy after Failure: A Prospective, Randomized Study

Ana Moreno, José Sanz, Víctor Abraira, 2002, Antiviral therapy.

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV

C. Fichtenbaum, J. Currier, J. Aberg, 2023, eBioMedicine.

Recent advances in rilpivirine: new data and promising treatment option.

J. Casado, S. Bañón, 2014, AIDS reviews.

COVID-19 and geographical area of origin

R. López-Vélez, P. Martín-Dávila, C. Crespillo-Andújar, 2020, Clinical Microbiology and Infection.

Human Monkeypox in People With HIV: Transmission, Clinical Features, and Outcome

L. Martínez-García, M. Pérez-Elías, J. Casado, 2022, Open forum infectious diseases.

Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity.

S. Moreno, M. Pérez-Elías, J. Casado, 2015, The Journal of antimicrobial chemotherapy.

Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

C. Quereda, S. Moreno, M. Pérez-Elías, 2012, Journal of acquired immune deficiency syndromes.

Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir

J. Casado, M. Vivancos, A. Moreno, 2019, Infectious diseases.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

D. Podzamczer, B. Clotet, J. Gatell, 2015, Enfermedades Infecciosas y Microbiologia Clinica.

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

A. Borobia, D. Podzamczer, Á. Soriano, 2021, The Lancet. Infectious diseases.

[Recessive distal myopathies. Five cases].

J. Casado, J. Bautista, M. Romero, 1995, Neurologia.

Validation of a Specific Questionnaire on Psychological and Social Repercussions of the Lipodystrophy Syndrome in HIV-infected Patients

S. Moreno, A. Antela, J. Casado, 2006, Quality of Life Research.

Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir

F. Liaño, J. Casado, C. Santiuste, 2016, AIDS.

[Cluster headache with a familial presentation].

J. Casado, R. Alberca, C. Arenas, 1994, Neurología.

The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients.

J. Casado, M. D. del Palacio, S. Romero, 2012, Current HIV research.

Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.

A. Guerrero, A. Antela, J. Casado, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Mycobacterial liver abscess in a patient with AIDS.

E. Gómez-Mampaso, J. Casado, V. Pintado, 1998, Postgraduate medical journal.

High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir

V. Abraira, S. Moreno, M. Pérez-Elías, 2005, AIDS.

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.

D. Podzamczer, B. Clotet, A. Winston, 2020, The Journal of antimicrobial chemotherapy.

Raltegravir plus Two Nucleoside Analogues as Combination Antiretroviral Therapy in HIV-Infected Patients who Require Cancer Chemotherapy

J. Moltó, J. Casado, A. Moreno, 2015, Antiviral therapy.

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

S. Moreno, M. Pérez-Elías, J. Casado, 2014, Journal of NeuroVirology.

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients

F. Liaño, S. Moreno, M. Pérez-Elías, 2016, Journal of acquired immune deficiency syndromes.

Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients

C. Quereda, J. Casado, P. Vizcarra, 2021, Viruses.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

“Real Life” Data on Daas Use among HCV-Patients with Moderate to Severe Chronic Kidney Disease not on Hemodialysis

C. Quereda, S. Moreno, M. Pérez-Elías, 2016 .

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

C. Quereda, S. Moreno, M. Pérez-Elías, 2004, AIDS.

Effect of Treatment With Efavirenz on Neuropsychiatric Adverse Events of Interferon in HIV/HCV-Coinfected Patients

C. Quereda, S. Moreno, M. Pérez-Elías, 2008, Journal of acquired immune deficiency syndromes.

Modifying dietary fat intake can reduce serum cholesterol in HIV-associated hypercholesterolemia

S. Moreno, J. Casado, 2016 .

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors

A. Carrato, F. Longo, J. Casado, 2023, Cancers.

Implementation of a lung cancer screening initiative in HIV-infected subjects

S. Moreno, M. Pérez-Elías, L. Gorospe, 2021, PloS one.

Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy

S. Moreno, M. Pérez-Elías, J. Casado, 2013, AIDS care.

Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.

S. Moreno, M. Pérez-Elías, A. Antela, 2003, AIDS.

Severity of the Toxicity Associated With Combinations That Include Didanosine Plus Stavudine in HIV-Infected Experienced Patients

S. Moreno, M. Pérez-Elías, A. Antela, 2006, Journal of Acquired Immune Deficiency Syndromes.

A Clinical Study of the Combination of 100 mg Ritonavir plus 800 mg Indinavir as Salvage Therapy: Influence of Increased Plasma Drug Levels in the Rate of Response

S. Moreno, M. Pérez-Elías, A. Antela, 2000, HIV clinical trials.

Patients Failing Saquinavir Therapy Require an Early Change to Indinavir before HIV-1 Viral Load Reaches High Levels

M. Pérez-Elías, A. Antela, J. Casado, 1998, Antiviral therapy.

A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.

D. Podzamczer, J. Miro, E. Martinez, 2001, The New England journal of medicine.

Progressive and parallel decline of humoral and T cell immunity in convalescent health care workers with asymptomatic or mild-moderate SARS-CoV-2 infection

J. Casado, P. Vizcarra, A. Vallejo, 2021, The Journal of infectious diseases.

Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection

J. Casado, 2021 .

mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection

J. Casado, P. Vizcarra, A. Vallejo, 2023, Frontiers in Immunology.

Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination

J. Casado, P. Vizcarra, A. Vallejo, 2023, Viruses.

SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study

J. Casado, P. Vizcarra, A. Vallejo, 2021, Clinical Microbiology and Infection.

[Potential role of rilpivirine in simplification regimens].

S. Moreno, J. Casado, 2013, Enfermedades infecciosas y microbiologia clinica.

Dose, Efficacy and Tolerability of Long-Term Indomethacin Treatment of Chronic Paroxysmal Hemicrania and Hemicrania Continua

J. Pareja, J. Pareja, J. Pascual, 2001, Cephalalgia : an international journal of headache.

Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART

S. Moreno, M. Pérez-Elías, J. Casado, 2013, HIV clinical trials.

CD4+:CD8+ T-cell Ratio Changes in People with HIV Receiving Antiretroviral Treatment

C. Sabin, C. Quereda, J. Galán, 2020, Antiviral therapy.

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients

S. Moreno, J. Casado, A. Moreno, 2014, Osteoporosis International.

Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.

J. Arribas, F. Pulido, J. Casado, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Central venous catheter infections in AIDS patients receiving daily home therapy for cytomegalovirus disease.

A. Guerrero, E. Navas, A. Antela, 1996, QJM : monthly journal of the Association of Physicians.

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection

C. Quereda, S. Moreno, M. Pérez-Elías, 2013, Journal of viral hepatitis.

Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy

E. Poveda, V. Soriano, J. Blanco, 2010, Antimicrobial Agents and Chemotherapy.

Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana

E. Negredo, E. Martinez, E. Martínez, 2014 .

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Miguel Ángel Martínez, B. Rodés, E. Poveda, 2023, EBioMedicine.

A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model

A. Curran, J. Casado, P. Vizcarra, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Relapsing Visceral Leishmaniasis in HIV-Infected Patients Undergoing Successful Protease Inhibitor Therapy

R. López-Vélez, C. Quereda, S. Moreno, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Limitations of a Simplification Antiretroviral Strategy for HIV-Infected Patients with Decreasing Adherence to a Protease Inhibitor Regimen

S. Moreno, M. Pérez-Elías, A. Antela, 2006, HIV clinical trials.

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

E. Negredo, J. Blanco, R. Montejano, 2019, Infectious diseases.

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

R. López-Vélez, J. Mallolas, E. Ribera, 2004, Enfermedades infecciosas y microbiologia clinica.

[Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients].

E. Negredo, E. Martinez, P. Carpintero, 2014, Enfermedades infecciosas y microbiologia clinica.